substance P, Pro(9)-

Substance P, Pro(9)- is a synthetic peptide analog derived from the neuropeptide substance P, with a proline substitution at the ninth amino acid position. As a member of the tachykinin peptide family, this compound is characterized by its ability to interact with neurokinin receptors, particularly the NK1 receptor, which plays a pivotal role in neurotransmission, pain perception, and neurogenic inflammation. The unique sequence modification at position 9 confers altered receptor binding properties and biological activity, making it a valuable tool for dissecting structure-activity relationships within the substance P family. Its well-defined biochemical properties and receptor selectivity have established it as a key reagent in neurobiology, pharmacology, and peptide signaling research.

Receptor pharmacology: Substance P, Pro(9)- is widely employed in studies investigating the pharmacological properties of neurokinin receptors. By introducing a proline residue at the ninth position, researchers can assess the impact of this modification on receptor binding affinity and selectivity, providing critical insights into ligand-receptor interactions. Such studies are fundamental for elucidating the molecular determinants of receptor activation and can inform the design of novel ligands with tailored pharmacological profiles.

Signal transduction research: The modified peptide serves as a valuable probe for exploring intracellular signaling cascades triggered by substance P and its analogs. Its interaction with NK1 and related receptors allows for the dissection of downstream pathways, such as G-protein coupled receptor signaling, calcium mobilization, and MAP kinase activation. This enables researchers to map the specific contributions of peptide structural elements to signaling efficacy and pathway bias, advancing the understanding of neuropeptide-mediated cellular responses.

Peptide structure-activity relationship analysis: Substance P, Pro(9)- is instrumental in systematic structure-activity relationship (SAR) studies, where it helps define the functional consequences of sequence alterations within the substance P backbone. By comparing its activity to that of native substance P and other analogs, investigators can delineate the roles of individual amino acid residues in receptor binding, activation, and biological effect. These insights are essential for rational peptide design and for the development of selective receptor modulators.

Neurobiology and pain mechanism modeling: The peptide analog is frequently utilized in experimental models to investigate the physiological and pathological roles of substance P in the central and peripheral nervous systems. Its altered activity profile makes it suitable for distinguishing between receptor subtypes and for probing the involvement of tachykinin pathways in nociception, neurogenic inflammation, and synaptic plasticity. Such applications contribute to a more nuanced understanding of pain mechanisms and neuropeptide function.

Peptide assay development: Substance P, Pro(9)- is also applied as a reference standard or competitor in quantitative and qualitative assays designed to measure neurokinin receptor activity. Its defined sequence and modified binding characteristics make it a useful control in high-throughput screening, binding assays, and functional bioassays. These applications support the validation of assay systems and facilitate the identification of novel modulators of neuropeptide signaling.

1. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate

2. Implications of ligand-receptor binding kinetics on GLP-1R signalling

3. Odorant binding protein based biomimetic sensors for detection of alcohols associated with Salmonella contamination in packaged beef

4. Identification, Localization in the Central Nervous System and Novel Myostimulatory Effect of Allatostatins in Tenebrio molitor Beetle

5. The spatiotemporal control of signalling and trafficking of the GLP-1R